GL1X · GenesisL1 explorer

MolNFT v1 · #185067 · protein

Crystal structure of a mutated form of rxralpha ligand binding domain in complex with BMS649 and a coactivator fragment

7PDT: “Crystal structure of a mutated form of rxralpha ligand binding domain in complex with BMS649 and a…”. X-ray diffraction, 1 ligand (BM6). MolNFT v1 #185067 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7PDT
Type
protein
Length
437 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P28700, Q15596
Ligands
BM6

Structure

x-ray diffraction · 4 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein209—P28700
U—protein11—Q15596
B—protein208—P28700
V—protein9—Q15596

Ligands and binding sites

  • BM6 · 4-[2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-[1,3]dioxolan-2-yl]-benzoic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 7PDT · Crystal structure of a mutated form of RXRalpha ligand binding domain in complex with… · the same entry in another collection · chain A against A, TM-score 1.00
  • P28700 · AlphaFold monomer V2.0 prediction for retinoic acid receptor rxr- alpha (P28700) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.